VIMTA LABS
Back to All Ratios
|
VIMTA LABS Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.89 | 2.26 | 2.31 | 1.39 | 0.64 |
What is the latest EV/CE ratio of VIMTA LABS ?
Year | EV/CE |
---|---|
Mar2024 | 2.89 |
Mar2023 | 2.26 |
Mar2022 | 2.31 |
Mar2021 | 1.39 |
Mar2020 | 0.64 |
How is EV/CE of VIMTA LABS Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.89 | 27.88 | |
Mar2023 | 2.26 | -2.16 | |
Mar2022 | 2.31 | 66.19 | |
Mar2021 | 1.39 | 117.19 | |
Mar2020 | 0.64 | - |
Other Financial Ratios of VIMTA LABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,340.3 Cr | 16.8% | 9.2% | 65.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 16.8% |
9.2% |
65.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses